MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) — Minneapolis, Minnesota

MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) is a clinical research site located in Minneapolis, Minnesota, United States 55416.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cancer, Pancreatic Cancer, Sarcoma.

Sponsors: Actuate Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC)?

MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) conducted?

MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) has 1 clinical trials on record, with 1 currently active. Their work covers Cancer, Pancreatic Cancer, Sarcoma.

Is MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) accredited by Crixeo Health?

MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.